Publication
Assessment of the acid phosphatase CP01850 from Corynebacterium pseudotuberculosis in DNA and subunit vaccine formulations against caseous lymphadenitis
Publisher:
FapUNIFESP (SciELO)
Date:
2020
DOI:
10.1590/1678-4162-10790
Abstract: ABSTRACT The target cp1002_RS01850 from Corynebacterium pseudotuberculosis was used to construct a DNA and recombinant subunit vaccine against caseous lymphadenitis. Recombinant protein rCP01850 was expressed in Escherichia coli using pAE vector, and DNA vaccine was engineered with pTARGET vector. BALB/c mice were ided in five groups containing eight animals each, inoculated with: pTARGET/cp01850 as DNA vaccine (G1) rCP01850 plus Al (OH)3 as recombinant subunit vaccine (G2) pTARGET/cp01850 and a boost with rCP01850 plus Al (OH)3 (G3) pTARGET (G4) or Al (OH)3 (G5). Mice were inoculated and blood s les were collected on days 0, 21, and 42 for the analysis of total IgG, IgG1 and IgG2a by ELISA. In each group, five animals were challenged with Mic-6 C. pseudotuberculosis strain, and three were used for cytokine quantification by qPCR. Although no group has been protected by vaccines against lethal challenge, G2 showed an increase in the survival rate after challenge. Significantly higher levels of IL-4, IL-12, IFN-γ, total IgG, IgG1 and IgG2a were also detected for G2, evidencing a mixed Th1/Th2 immunological profile. In conclusion, despite no protection level provided by different vaccinal strategies using cp1002_RS01850 from C. pseudotuberculosis, G2 developed a Th1/Th2 immune response with an increase in survival rate.